Our partner is focused on developing therapies for rare and autoimmune diseases. Their approach targets key drivers of inflammation to address unmet medical needs, with the goal of improving patient outcomes and quality of life through innovative treatments.

This critical hire led the development and maintenance of the global quality system, ensuring compliance with regulatory requirements for both internal manufacturing and CDMOs. They oversaw quality systems for biologics, driving risk analysis, mitigation strategies, and continuous improvement. With over 10 years of experience in the biotech industry, they provided leadership in managing internal and external quality assurance functions, supporting the organization's growth and regulatory goals.